
by Recursion
Recursion is a clinical-stage TechBio company that uses an AI-enabled engine linking automated labs, models and clinical development to discover medicines. It advances a pipeline in oncology and rare disease.
Web appContact for pricing
Step 1: Read the technology pages to see how the engine works.
Step 2: Browse the pipeline by target, indication and stage.
Step 3: Read the partnering page to see how Recursion works with pharma teams.
Step 4: Contact the team through the details on the site.
The FAQ describes it as a clinical-stage TechBio company decoding biology to improve lives.
The site mentions oncology and rare disease, with programs such as REC-4881 in familial adenomatous polyposis.
Wet and dry labs form a continuous learning system that combines physical automation and machine learning models.
Yes. It advances joint portfolios with pharma partners, including a collaboration with Genentech.
Chai-1Multimodal foundation model for predicting biomolecular structures and interactions across proteins, ligands, nucleic acids, and complexes